According to Immatics's latest financial reports the company has $0.47 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.38 B | 136.03% |
2021-12-31 | $0.16 B | -42.4% |
2020-12-31 | $0.28 B | 113.37% |
2019-12-31 | $0.13 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.13 M | -99.97% | Bahamas |
NRC Health
NRC | $6.65 M | -98.59% | ๐บ๐ธ USA |